Immunosuppression compound and treatment method

Details for Australian Patent Application No. 2009313359 (hide)

Owner AVI BioPharma, Inc.

Inventors Mourich, Dan V.; Iversen, Patrick L.; Weller, Dwight D.

Agent Davies Collison Cave

Pub. Number AU-A-2009313359

PCT Pub. Number WO2010/054267

Priority 12/267,437 07.11.08 US

Filing date 6 November 2009

Wipo publication date 14 May 2010

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/054267 Priority application(s): WO2010/054267

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313363-Coil shooting mode

2009313358-Multiblock copolymers